Dariohealth Corp Stock Return On Equity
| DRIO Stock | USD 1.50 0.05 3.45% |
DarioHealth Corp fundamentals help investors to digest information that contributes to DarioHealth Corp's financial success or failures. It also enables traders to predict the movement of DarioHealth Stock. The fundamental analysis module provides a way to measure DarioHealth Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DarioHealth Corp stock.
| Last Reported | Projected for Next Year | ||
| Return On Equity | (0.94) | (0.90) |
DarioHealth | Return On Equity |
DarioHealth Corp Company Return On Equity Analysis
DarioHealth Corp's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current DarioHealth Corp Return On Equity | -0.86 |
Most of DarioHealth Corp's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DarioHealth Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
DarioHealth Return On Equity Driver Correlations
Understanding the fundamental principles of building solid financial models for DarioHealth Corp is extremely important. It helps to project a fair market value of DarioHealth Stock properly, considering its historical fundamentals such as Return On Equity. Since DarioHealth Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DarioHealth Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DarioHealth Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
DarioHealth Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, DarioHealth Corp has a Return On Equity of -0.8604. This is 96.41% lower than that of the Health Care Equipment & Supplies sector and 87.12% lower than that of the Health Care industry. The return on equity for all United States stocks is 177.55% higher than that of the company.
DarioHealth Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DarioHealth Corp's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DarioHealth Corp could also be used in its relative valuation, which is a method of valuing DarioHealth Corp by comparing valuation metrics of similar companies.DarioHealth Corp is currently under evaluation in return on equity category among related companies.
DarioHealth Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of DarioHealth Corp from analyzing DarioHealth Corp's financial statements. These drivers represent accounts that assess DarioHealth Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of DarioHealth Corp's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 14.9M | 85.2M | 215.2M | 101.2M | 48.8M | 37.0M | |
| Enterprise Value | (4.8M) | 57.2M | 179.7M | 79.8M | 41.3M | 27.6M |
DarioHealth Fundamentals
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.33 | ||||
| Profit Margin | (2.92) % | ||||
| Operating Margin | (3.90) % | ||||
| Current Valuation | 35.44 M | ||||
| Shares Outstanding | 29.68 M | ||||
| Shares Owned By Insiders | 14.81 % | ||||
| Shares Owned By Institutions | 29.43 % | ||||
| Number Of Shares Shorted | 1.38 M | ||||
| Price To Earning | (2.30) X | ||||
| Price To Book | 0.62 X | ||||
| Price To Sales | 1.78 X | ||||
| Revenue | 20.35 M | ||||
| Gross Profit | 14.01 M | ||||
| EBITDA | (50.84 M) | ||||
| Net Income | (54.86 M) | ||||
| Cash And Equivalents | 67.95 M | ||||
| Cash Per Share | 2.96 X | ||||
| Total Debt | 29.54 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 6.35 X | ||||
| Book Value Per Share | 2.14 X | ||||
| Cash Flow From Operations | (30.38 M) | ||||
| Short Ratio | 11.53 X | ||||
| Earnings Per Share | (1.93) X | ||||
| Target Price | 5.67 | ||||
| Number Of Employees | 276 | ||||
| Beta | 1.66 | ||||
| Market Capitalization | 44.51 M | ||||
| Total Asset | 96.39 M | ||||
| Retained Earnings | (349.36 M) | ||||
| Working Capital | 34.84 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 1.69 M | ||||
| Net Asset | 96.39 M |
About DarioHealth Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DarioHealth Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DarioHealth Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DarioHealth Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving against DarioHealth Stock
| 0.76 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.74 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.73 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
| 0.7 | NXL | Nexalin Technology | PairCorr |
| 0.62 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out DarioHealth Corp Piotroski F Score and DarioHealth Corp Altman Z Score analysis. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for DarioHealth Stock analysis
When running DarioHealth Corp's price analysis, check to measure DarioHealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DarioHealth Corp is operating at the current time. Most of DarioHealth Corp's value examination focuses on studying past and present price action to predict the probability of DarioHealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DarioHealth Corp's price. Additionally, you may evaluate how the addition of DarioHealth Corp to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is DarioHealth Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.93) | Revenue Per Share 0.717 | Quarterly Revenue Growth (0.47) | Return On Assets (0.33) | Return On Equity (0.86) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.